Health care stocks edged up late Monday afternoon, with the NYSE Health Care Index adding 0.3% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%.
The iShares Biotechnology ETF (IBB) gained 0.9%.
In corporate news, PROCEPT BioRobotics (PRCT) shares surged past 31% after the company released Q3 results that were above market expectations and raised its revenue outlook for 2024.
Monte Rosa Therapeutics (GLUE) shares soared 98%. The company said Monday that it signed a global development and commercialization license agreement with Novartis (NVS) for VAV1-directed molecular glue degraders, including MRT-6160. Novartis shares rose 1.7%.
Vera Therapeutics (VERA) shares jumped past 15% after the company disclosed long-term efficacy and favorable safety data from its phase 2b trial of kidney disease treatment candidate atacicept.
Royal Philips (PHG) shares tumbled past 16%. The company cut its full-year comparable sales growth outlook amid a substantial drop in demand in China, while Q3 earnings were little changed.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。